Wednesday, 26 January, 2022

Eskayef produces Remdesivir in Bangladesh

Eskayef produces Remdesivir in Bangladesh

Eskayef Pharmaceuticals Limited has completed the production of Remdisivir, the drug which is proved to be effective in treating COVID-19 patients.

After completion of all production process, the company started to distribute the drug on Friday, according to a media statement.

Managing Director and Chief Executive Officer of Eskayef Simeen Hossain in a media statement said, we are glad to inform you that Remdesivir, the only effective drug against coronavirus, is now at our hands.

Remdesivir, a drug developed by Gilead Sciences in the US, has grabbed attention as one of the most promising treatments for Covid-19, the respiratory disease caused by the novel coronavirus that has killed more than 250,000 people.

It got the approval of US Food and Drug Administration (FDA) as a drug against coronavirus last week.

The brand name for Remdesivir manufactured by Eskayef is Remivir.